Cytomation, Inc. is a global leader in the design and manufacture of high-performance cell sorters and analyzers. Scientists at universities, research hospitals, and pharmaceutical companies use Cytomation's flow cytometry technology for biomedical research, such as drug discovery and stem cell and gene therapy. Headquartered in Fort Collins, Colorado, USA, Cytomation employs 150 people. The privately held company has sales and service offices in Germany and Australia, with distributors throughout Europe and Asia. This press release does not constitute an offer of any securities for sale.